Drug Shortage Report for SANDOZ IRBESARTAN

Last updated on 2021-04-20 History
Report ID 137135
Drug Identification Number 02328488
Brand name SANDOZ IRBESARTAN
Common or Proper name SANDOZ IRBESARTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 10LIIF CA
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-04-01
Estimated end date 2021-04-16
Actual end date 2021-04-16
Shortage status Resolved
Updated date 2021-04-20
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-20 French Compare
v5 2021-04-20 English Compare
v4 2021-04-12 French Compare
v3 2021-04-12 English Compare
v2 2021-04-08 French Compare
v1 2021-04-08 English Compare